Literature DB >> 18992314

Lipid nanoparticles (SLN, NLC) in cosmetic and pharmaceutical dermal products.

Jana Pardeike1, Aiman Hommoss, Rainer H Müller.   

Abstract

Solid lipid nanoparticles (SLN) are distinguishable from nanostructured lipid carriers (NLC) by the composition of the solid particle matrix. Both are an alternative carrier system to liposomes and emulsions. This review paper focuses on lipid nanoparticles for dermal application. Production of lipid nanoparticles and final products containing lipid nanoparticles is feasible by well-established production methods. SLN and NLC exhibit many features for dermal application of cosmetics and pharmaceutics, i.e. controlled release of actives, drug targeting, occlusion and associated with it penetration enhancement and increase of skin hydration. Due to the production of lipid nanoparticles from physiological and/or biodegradable lipids, this carrier system exhibits an excellent tolerability. The lipid nanoparticles are a "nanosafe" carrier. Furthermore, an overview of the cosmetic products currently on the market is given and the improvement of the benefit/risk ratio of the topical therapy is shown.

Entities:  

Mesh:

Substances:

Year:  2008        PMID: 18992314     DOI: 10.1016/j.ijpharm.2008.10.003

Source DB:  PubMed          Journal:  Int J Pharm        ISSN: 0378-5173            Impact factor:   5.875


  157 in total

1.  Nanostructured lipid carriers (NLC) for parenteral delivery of an anticancer drug.

Authors:  Akhayacatra Chinsriwongkul; Ponwanit Chareanputtakhun; Tanasait Ngawhirunpat; Theerasak Rojanarata; Warisada Sila-on; Uracha Ruktanonchai; Praneet Opanasopit
Journal:  AAPS PharmSciTech       Date:  2011-12-14       Impact factor: 3.246

2.  Application of nanotechnology in cosmetics.

Authors:  Li Mu; Robert L Sprando
Journal:  Pharm Res       Date:  2010-04-21       Impact factor: 4.200

Review 3.  A review of nanotechnological approaches for the prophylaxis of HIV/AIDS.

Authors:  Abhijit A Date; Christopher J Destache
Journal:  Biomaterials       Date:  2013-05-28       Impact factor: 12.479

4.  Nanoparticles do not penetrate human skin--a theoretical perspective.

Authors:  Adam C Watkinson; Annette L Bunge; Jonathan Hadgraft; Majella E Lane
Journal:  Pharm Res       Date:  2013-05-31       Impact factor: 4.200

5.  Ivermectin lipid-based nanocarriers as novel formulations against head lice.

Authors:  Gabriela Ullio-Gamboa; Santiago Palma; Jean Pierre Benoit; Daniel Allemandi; María Inés Picollo; Ariel Ceferino Toloza
Journal:  Parasitol Res       Date:  2017-05-18       Impact factor: 2.289

6.  Multiple Lipid Nanoparticles (MLN), a New Generation of Lipid Nanoparticles for Drug Delivery Systems: Lamivudine-MLN Experimental Design.

Authors:  Suellen M T Cavalcanti; Cláudia Nunes; Sofia A C Lima; José L Soares-Sobrinho; Salette Reis
Journal:  Pharm Res       Date:  2017-03-17       Impact factor: 4.200

7.  Formulation and evaluation of Adapalene-loaded nanoparticulates for epidermal localization.

Authors:  Mangesh Bhalekar; Prashant Upadhaya; Ashwini Madgulkar
Journal:  Drug Deliv Transl Res       Date:  2015-12       Impact factor: 4.617

8.  Squalene-containing nanostructured lipid carriers promote percutaneous absorption and hair follicle targeting of diphencyprone for treating alopecia areata.

Authors:  Yin-Ku Lin; Saleh A Al-Suwayeh; Yann-Lii Leu; Feng-Ming Shen; Jia-You Fang
Journal:  Pharm Res       Date:  2012-10-16       Impact factor: 4.200

9.  Co-delivery of siRNA and therapeutic agents using nanocarriers to overcome cancer resistance.

Authors:  Mar Creixell; Nicholas A Peppas
Journal:  Nano Today       Date:  2012-08-01       Impact factor: 20.722

Review 10.  Nanotechnology applications for the therapy of liver fibrosis.

Authors:  Lydia Giannitrapani; Maurizio Soresi; Maria Luisa Bondì; Giuseppe Montalto; Melchiorre Cervello
Journal:  World J Gastroenterol       Date:  2014-06-21       Impact factor: 5.742

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.